Intrinsic laryngeal muscles are spared from myonecrosis in the mdx mouse model of Duchenne muscular dystrophy

Muscle and Nerve

Volumn 35, Issue 3, 2007, Pages 349-353

  Marques, Maria Julia ^a   Ferretti, Renato ^a   Vomero, Viviane Urbini ^a   Minatel, Elaine ^a   Neto, Humberto Santo ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Aging; Dystrophin; Intrinsic laryngeal muscles; mdx mouse; Muscle regeneration

Indexed keywords

DYSTROPHIN; EVANS BLUE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRICOPHARYNGEUS MUSCLE; DISEASE MARKER; DUCHENNE MUSCULAR DYSTROPHY; EXTRAOCULAR MUSCLE; LARYNX MUSCLE; MALE; MOUSE; MUSCLE CELL; MUSCLE NECROSIS; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; TIBIALIS ANTERIOR MUSCLE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

EID: 33847684752     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20697     Document Type: Article

References (27)

1. Andrade FH, Porter JD, Kaminski HJ. Eye muscle sparing by the muscular dystrophies: lessons to be learned? Microsc Res Technol 2000;8:192-203.
2. Bain NL, Knight MA, O'Donnell L, Murdoch BE, Trezise AEO. Adult mouse intrinsic laryngeal muscles express high levels of the myogenic regulatory factor, Myf-5. J Med Speech-Lang Pathol 2001;9:157-167.
3. Baker PE, Kearney JA, Gong B, Merriam AP, Kuhn DE, Porter JD, et al. Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscles genes in limb muscles. Neurogenetics 2006;7:81-91.
4. Blank JM, Schachat F. Extraocular and laryngeal muscles exhibit differential amplification of protein involved in calcium homeostasis. Mol Biol Cell 1999;10:246A.
5. Budak MT, Bogdanovich S, Wiesen MHJ, Lozynska O, Khurana TS, Rubinstein NA. Layer-specific differences of gene expression in extraocular muscles identified by laser-capture microscopy. Physiol Genomics 2004;20:55-65.
6. Bulfield G, Siller WG, Wight PAL, Moore KJ. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 1984;81:1189-1192.
7. Celio MR, Heizmann CW. Calcium-binding protein parvalbumin as a neuronal marker. Nature 1981;293:300-302.
8. Coulton GR, Morgan JE, Partridge TA, Sloper JC. The mdx mouse skeletal muscle myopathy. I. A histological, morphometric and biochemical investigation. Neuropathol Appl Neurobiol 1988;14:53-70.
9. Dubowitz V. What is muscular dystrophy? Forty years of progressive ignorance. J R Coll Phys Lond 2000;34:464-468.
10. Engel AG, Yamamoto M, Fischbeck KH. Muscular dystrophies. In: Engel AG, Franzini-Armstrong C, editors. Myology. Vol. 2. New York: McGraw-Hill; 1994. p 1133-1187.
11. Goding GS, Al-Sharif KI, McLoon LK. Myonuclear addition to uninjured laryngeal myofibers in adult rabbits. Ann Otol Rhinol Laryngol 2005;114:552-557.
12. Hamer PW, McGeachie JM, Davies MJ, Grounds MD. Evans blue dye as an in vivo marker of myofibre damage: optimizing parameters for detecting initial myofibre membrane permeability. J Anat 2002;200:69-79.
13. Hoffman EP, Brown RH Jr, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987;51:919-928.
14. Hoh JFY. Laryngeal muscle fibre types. Acta Physiol Scand 2005;183:133-149.
15. Kersing W, Jennekens FGI. Age-related changes in human thyroarytenoid muscles: a histological and histochemical study. Eur Arch Otorhinolaryngol 2004;261:386-392.
16. Khurana TS, Predergast RA, Alameddine HS, et al. Absence of extraocular muscle pathology in Duchenne's muscular dystrophy: role for calcium homeostasis in extraocular muscle sparing. J Exp Med 1995;182:467-474.
17. Lefaucheur JP, Pastoret C, Sebille A. Phenotype of dystrophinopathy in old mdx mice. Anat Rec 1995;242:70-76.
18. Lucas CA, Rughani A, Hoh JFY. Expression of extraocular myosin heavy chain in rabbit laryngeal muscle. J Muscle Res Cell Motil 1995;16:368-378.
19. Malmgren LT, Lovice DB, Kaufman MR. Age-related changes in muscle fiber regeneration in the human thyroaiytenoid muscle. Arch Otolaryngol Head Neck Surg 2000;126:851-856.
20. McLoon LK, Rowe J, Wirtschafter J, McCormick KM. Continuous myofiber remodeling in uninjured extraocular myofibers; myonuclear turnover and evidence for apoptosis. Muscle Nerve 2004;29:707-715.
21. Pastoret C, Sebille A. mdx mice show progressive weakness and muscle deterioration with age. J Neurol Sci 1995;129:97-105.
22. Porter JD, Israel S, Gong BD, Merriam AP, Feuerman J, Khanna S, et al. Distinctive morphological and gene/protein expression signatures during myogenesis in novel cell lines from extraocular and hindlimb muscle. Physiol Genomics 2006;24:264-275.
23. Porter JD, Baker RS. Muscles of a different color: the unusual properties of the extraocular muscles may predispose or protect them in neurogenic and myogenic disease. Neurology 1996;46:30-37.
24. Porter JD, Baker RS, Ragusa RJ, Brueckner JK. Extraocular muscles: basic and clinical aspects of structure and function. Surv Ophthalmol 1995;39:451-484.
25. Rhee HS, Lucas CA, Hoh JF. Fiber types in rat laryngeal muscles and their transformations after denervation and reinnervation. J Histochem Cytochem 2004;52:581-590.
26. Torres LBF, Duchen LW. The mutant mdx: inherited myopathy in the mouse. Brain 1987;110:269-299.
27. Yu Wai Man CY, Chinnery PF, Griffiths PG. Extraocular muscles have fundamentally distinct properties that make them selectively vulnerable to certain disorders. Neuromuscul Disord 2005;15:17-23.